肢端黑色素瘤远处转移的多因素分析及预测模型构建。

IF 2.9 3区 医学 Q2 ONCOLOGY
American journal of cancer research Pub Date : 2025-08-25 eCollection Date: 2025-01-01 DOI:10.62347/OLPB3585
Jiabin Deng, Mengru Gao, Hailin Yao, Junjun Wu, Lei Cui, Xiaojing Li
{"title":"肢端黑色素瘤远处转移的多因素分析及预测模型构建。","authors":"Jiabin Deng, Mengru Gao, Hailin Yao, Junjun Wu, Lei Cui, Xiaojing Li","doi":"10.62347/OLPB3585","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the pathological characteristics of Acral Melanoma (AM) patients and identify the factors influencing distant metastasis, while constructing a predictive model for distant metastasis-free survival (DMFS).</p><p><strong>Methods: </strong>Conducted on 229 AM patients admitted to the Third People's Hospital of Bengbu and The First Affiliated Hospital of Anhui Medical University from January 1, 2012, to December 31, 2024. Data collected included gender, age, lesion location, initial diagnosis stage, trauma history, ulcer presence, Breslow thickness, mitotic rate, lactate dehydrogenase (LDH), albumin (Alb), and adjuvant therapy. DMFS was assessed through follow-up, with a deadline of March 31, 2025. Statistical analysis was performed to evaluate significant factors influencing distant metastasis.</p><p><strong>Results: </strong>The incidence of AM showed an increasing trend from 2012 to 2024. Of the 229 patients, 78 (34.06%) developed distant metastasis. The median follow-up period was 37 months, and 1-year, 3-year, and 5-year survival rates without distant metastasis were 93.45%, 74.24%, and 66.81%, respectively. Statistically significant factors affecting DMFS included initial diagnosis stage, ulcer presence, Breslow thickness, mitotic rate, LDH, and Alb levels (all P<0.05). Risk factors for distant metastasis included stage III at diagnosis, ulcer presence, lack of adjuvant therapy, elevated LDH, and low Alb levels.</p><p><strong>Conclusions: </strong>The study identified key pathological factors influencing distant metastasis in AM patients. The constructed nomogram model demonstrated good predictive accuracy, with AUC values of 0.895 and 0.879 in the training and validation sets, respectively. This model can aid in the clinical screening of AM patients at risk for distant metastasis.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"15 8","pages":"3678-3692"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432569/pdf/","citationCount":"0","resultStr":"{\"title\":\"Multivariate analysis and prediction model construction for distant metastasis of Acral Melanoma.\",\"authors\":\"Jiabin Deng, Mengru Gao, Hailin Yao, Junjun Wu, Lei Cui, Xiaojing Li\",\"doi\":\"10.62347/OLPB3585\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To analyze the pathological characteristics of Acral Melanoma (AM) patients and identify the factors influencing distant metastasis, while constructing a predictive model for distant metastasis-free survival (DMFS).</p><p><strong>Methods: </strong>Conducted on 229 AM patients admitted to the Third People's Hospital of Bengbu and The First Affiliated Hospital of Anhui Medical University from January 1, 2012, to December 31, 2024. Data collected included gender, age, lesion location, initial diagnosis stage, trauma history, ulcer presence, Breslow thickness, mitotic rate, lactate dehydrogenase (LDH), albumin (Alb), and adjuvant therapy. DMFS was assessed through follow-up, with a deadline of March 31, 2025. Statistical analysis was performed to evaluate significant factors influencing distant metastasis.</p><p><strong>Results: </strong>The incidence of AM showed an increasing trend from 2012 to 2024. Of the 229 patients, 78 (34.06%) developed distant metastasis. The median follow-up period was 37 months, and 1-year, 3-year, and 5-year survival rates without distant metastasis were 93.45%, 74.24%, and 66.81%, respectively. Statistically significant factors affecting DMFS included initial diagnosis stage, ulcer presence, Breslow thickness, mitotic rate, LDH, and Alb levels (all P<0.05). Risk factors for distant metastasis included stage III at diagnosis, ulcer presence, lack of adjuvant therapy, elevated LDH, and low Alb levels.</p><p><strong>Conclusions: </strong>The study identified key pathological factors influencing distant metastasis in AM patients. The constructed nomogram model demonstrated good predictive accuracy, with AUC values of 0.895 and 0.879 in the training and validation sets, respectively. This model can aid in the clinical screening of AM patients at risk for distant metastasis.</p>\",\"PeriodicalId\":7437,\"journal\":{\"name\":\"American journal of cancer research\",\"volume\":\"15 8\",\"pages\":\"3678-3692\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432569/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.62347/OLPB3585\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/OLPB3585","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:分析肢端黑色素瘤(Acral Melanoma, AM)患者的病理特征,探讨影响远端转移的因素,建立远端无转移生存期(DMFS)预测模型。方法:选取蚌埠市第三人民医院和安徽医科大学第一附属医院2012年1月1日至2024年12月31日住院的AM患者229例。收集的数据包括性别、年龄、病变部位、初始诊断阶段、创伤史、溃疡存在、Breslow厚度、有丝分裂率、乳酸脱氢酶(LDH)、白蛋白(Alb)和辅助治疗。对DMFS进行了后续评估,截止日期为2025年3月31日。统计学分析影响远处转移的重要因素。结果:2012 - 2024年AM发病率呈上升趋势。229例患者中,78例(34.06%)发生远处转移。中位随访时间为37个月,无远处转移的1年、3年和5年生存率分别为93.45%、74.24%和66.81%。影响AM患者DMFS有统计学意义的因素包括初诊阶段、溃疡存在、Breslow厚度、有丝分裂率、LDH和Alb水平(均为p)。结论:本研究确定了影响AM患者远处转移的关键病理因素。所构建的模态图模型具有较好的预测精度,训练集和验证集的AUC分别为0.895和0.879。该模型可以帮助临床筛选有远处转移风险的AM患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multivariate analysis and prediction model construction for distant metastasis of Acral Melanoma.

Objective: To analyze the pathological characteristics of Acral Melanoma (AM) patients and identify the factors influencing distant metastasis, while constructing a predictive model for distant metastasis-free survival (DMFS).

Methods: Conducted on 229 AM patients admitted to the Third People's Hospital of Bengbu and The First Affiliated Hospital of Anhui Medical University from January 1, 2012, to December 31, 2024. Data collected included gender, age, lesion location, initial diagnosis stage, trauma history, ulcer presence, Breslow thickness, mitotic rate, lactate dehydrogenase (LDH), albumin (Alb), and adjuvant therapy. DMFS was assessed through follow-up, with a deadline of March 31, 2025. Statistical analysis was performed to evaluate significant factors influencing distant metastasis.

Results: The incidence of AM showed an increasing trend from 2012 to 2024. Of the 229 patients, 78 (34.06%) developed distant metastasis. The median follow-up period was 37 months, and 1-year, 3-year, and 5-year survival rates without distant metastasis were 93.45%, 74.24%, and 66.81%, respectively. Statistically significant factors affecting DMFS included initial diagnosis stage, ulcer presence, Breslow thickness, mitotic rate, LDH, and Alb levels (all P<0.05). Risk factors for distant metastasis included stage III at diagnosis, ulcer presence, lack of adjuvant therapy, elevated LDH, and low Alb levels.

Conclusions: The study identified key pathological factors influencing distant metastasis in AM patients. The constructed nomogram model demonstrated good predictive accuracy, with AUC values of 0.895 and 0.879 in the training and validation sets, respectively. This model can aid in the clinical screening of AM patients at risk for distant metastasis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
3.80%
发文量
263
期刊介绍: The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信